{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:32:02Z","timestamp":1775039522964,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP177524"],"award-info":[{"award-number":["APP177524"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP177524"],"award-info":[{"award-number":["APP177524"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP177524"],"award-info":[{"award-number":["APP177524"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["IIRS-21-102"],"award-info":[{"award-number":["IIRS-21-102"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast cancer remains a significant global health challenge. In Australia, the adoption of publicly-funded multigene panel testing for eligible cancer patients has increased accessibility to personalised care, yet has also highlighted the increasing prevalence of variants of uncertain significance (VUS), complicating clinical decision-making. This project aimed to explore the spectrum and actionability of breast cancer VUS in Australian familial cancer centers (FCCs). Leveraging data from 11 FCCs participating in the Inherited Cancer Connect database, we retrieved VUS results from 1472 patients. Through ClinVar crosschecks and application of gene-specific ACMG\/AMP guidelines, we showed the potential for reclassification of 4% of unique VUS as pathogenic or likely pathogenic, and 80% as benign or likely benign. Surveys conducted with FCCs and diagnostic laboratories described current practices and challenges in variant reclassifications, highlighting resource constraints preventing periodic VUS review and notifications from the laboratories to the FCCs. Our study suggests there are benefits to routine VUS review and reclassification, particularly in publicly-funded healthcare systems. Future research should focus on assessing the clinical impact and cost-effectiveness of implementing routine variant review practices, alongside efforts to enhance communication between FCCs and laboratories.<\/jats:p>","DOI":"10.1038\/s41431-024-01705-9","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T15:02:08Z","timestamp":1728918128000},"page":"1632-1639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres"],"prefix":"10.1038","volume":"32","author":[{"given":"Cristina","family":"Fortuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa J.","family":"Cops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5034-5996","authenticated-orcid":false,"given":"Aimee L.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Hadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6909-2412","authenticated-orcid":false,"given":"Giovanni","family":"Innella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddison E.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-8477","authenticated-orcid":false,"given":"Michael","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainsley M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9585-1136","authenticated-orcid":false,"given":"Andrew","family":"Dubowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verna","family":"Fargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7455-934X","authenticated-orcid":false,"given":"Michael J.","family":"Field","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen G.","family":"Mar Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra B.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9372-3325","authenticated-orcid":false,"given":"Nicola K.","family":"Poplawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Warwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Beshay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Johns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"McPhillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Siva","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1294-1110","authenticated-orcid":false,"given":"Mark","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5813-631X","authenticated-orcid":false,"given":"Hamish","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4361-4657","authenticated-orcid":false,"given":"Paul A.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-7897","authenticated-orcid":false,"given":"Amanda B.","family":"Spurdle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"1705_CR1","first-page":"145","volume":"8","author":"MJ Larsen","year":"2014","unstructured":"Larsen MJ, Thomassen M, Gerdes AM, Kruse TA. Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast Cancer. 2014;8:145\u201355.","journal-title":"Breast Cancer."},{"key":"1705_CR2","first-page":"369","volume":"30","author":"A Mehrgou","year":"2016","unstructured":"Mehrgou A, Akouchekian M. The importance of BRCA1 and BRCA2 genes mutations in breast cancer development. Med J Islam Repub Iran. 2016;30:369.","journal-title":"Med J Islam Repub Iran."},{"key":"1705_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1158\/1055-9965.EPI-19-0506","volume":"29","author":"B Adedokun","year":"2020","unstructured":"Adedokun B, Zheng Y, Ndom P, Gakwaya A, Makumbi T, Zhou AY, et al. Prevalence of Inherited Mutations in Breast Cancer Predisposition Genes among Women in Uganda and Cameroon. Cancer Epidemiol Biomark Prev. 2020;29:359\u201367.","journal-title":"Cancer Epidemiol Biomark Prev."},{"key":"1705_CR4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","volume":"21","author":"MB Daly","year":"2023","unstructured":"Daly MB, Pal T, Maxwell KN, Churpek J, Kohlmann W, AlHilli Z, et al. NCCN Guidelines\u00ae Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. J Natl Compr Canc Netw. 2023;21:1000\u201310.","journal-title":"J Natl Compr Canc Netw."},{"key":"1705_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102522","volume":"114","author":"E Blondeaux","year":"2023","unstructured":"Blondeaux E, Arecco L, Punie K, Graffeo R, Toss A, De Angelis C, et al. Germline TP53 pathogenic variants and breast cancer: A narrative review. Cancer Treat Rev. 2023;114:102522.","journal-title":"Cancer Treat Rev."},{"key":"1705_CR6","doi-asserted-by":"publisher","first-page":"e4975","DOI":"10.1097\/MD.0000000000004975","volume":"95","author":"Z Baretta","year":"2016","unstructured":"Baretta Z, Mocellin S, Goldin E, Olopade OI, Huo D. Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis. Medicine. 2016;95:e4975.","journal-title":"Medicine."},{"key":"1705_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12687-022-00594-z","volume":"13","author":"Y Amano","year":"2022","unstructured":"Amano Y, Raz A, Timmermans S, Shkedi-Rafid S. Cancer patients\u2019 understandings of genetic variants of uncertain significance in clinical care. J Community Genet. 2022;13:381\u20138.","journal-title":"J Community Genet."},{"key":"1705_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jgc4.1075","volume":"28","author":"S Makhnoon","year":"2019","unstructured":"Makhnoon S, Shirts BH, Bowen DJ. Patients\u2019 perspectives of variants of uncertain significance and strategies for uncertainty management. J Genet Couns. 2019;28:313\u201325.","journal-title":"J Genet Couns."},{"key":"1705_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/jgc4.1680","volume":"32","author":"EY Chang","year":"2023","unstructured":"Chang EY, Solomon I, Culver JO, Gorman N, Comeaux JG, Lerman C, et al. Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels. J Genet Couns. 2023;32:706\u201316.","journal-title":"J Genet Couns."},{"key":"1705_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100947","volume":"25","author":"HL Rehm","year":"2023","unstructured":"Rehm HL, Alaimo JT, Aradhya S, Bayrak-Toydemir P, Best H, Brandon R, et al. The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change. Genet Med. 2023;25:100947.","journal-title":"Genet Med."},{"key":"1705_CR11","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980\u20135.","journal-title":"Nucleic Acids Res."},{"key":"1705_CR12","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1002\/cam4.5202","volume":"12","author":"S Makhnoon","year":"2023","unstructured":"Makhnoon S, Levin B, Ensinger M, Mattie K, Volk RJ, Zhao Z, et al. A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes. Cancer Med. 2023;12:2875\u201384.","journal-title":"Cancer Med."},{"key":"1705_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/s41436-018-0335-7","volume":"21","author":"GJ Tsai","year":"2019","unstructured":"Tsai GJ, Ra\u00f1ola JMO, Smith C, Garrett LT, Bergquist T, Casadei S, et al. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance. Genet Med. 2019;21:1435\u201342.","journal-title":"Genet Med."},{"key":"1705_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12282-019-00951-w","volume":"26","author":"MK So","year":"2019","unstructured":"So MK, Jeong TD, Lim W, Moon BI, Paik NS, Kim SC, et al. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast\/ovarian cancer using the ACMG\/AMP 2015 guidelines. Breast Cancer. 2019;26:510\u20139.","journal-title":"Breast Cancer."},{"key":"1705_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/jmg-2023-109694","volume":"61","author":"G Innella","year":"2024","unstructured":"Innella G, Ferrari S, Miccoli S, Luppi E, Fortuno C, Parsons MT, et al. Clinical implications of VUS reclassification in a single-centre series from application of ACMG\/AMP classification rules specified for BRCA1\/2. J Med Genet. 2024;61:483\u20139.","journal-title":"J Med Genet."},{"key":"1705_CR16","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e83","volume":"31","author":"HI Ha","year":"2020","unstructured":"Ha HI, Ryu JS, Shim H, Kong SY, Lim MC. Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers. J Gynecologic Oncol. 2020;31:e83.","journal-title":"J Gynecologic Oncol."},{"key":"1705_CR17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s12282-020-01119-7","volume":"27","author":"D Li","year":"2020","unstructured":"Li D, Shi Y, Li A, Cao D, Su H, Yang H, et al. Retrospective reinterpretation and reclassification of BRCA1\/2 variants from Chinese population. Breast Cancer. 2020;27:1158\u201367.","journal-title":"Breast Cancer."},{"key":"1705_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13045-020-01010-0","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang H, Wang X, Liu J, Li J, Wang X, et al. Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort. J Hematol Oncol. 2021;14:18.","journal-title":"J Hematol Oncol."},{"key":"1705_CR19","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btab051","volume":"37","author":"M Lefter","year":"2021","unstructured":"Lefter M, Vis JK, Vermaat M, den Dunnen JT, Taschner PEM, Laros JFJ. Mutalyzer 2: next generation HGVS nomenclature checker. Bioinformatics. 2021;37:2811\u20137.","journal-title":"Bioinformatics."},{"key":"1705_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625:92\u2013100.","journal-title":"Nature."},{"key":"1705_CR21","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","volume":"110","author":"LC Walker","year":"2023","unstructured":"Walker LC, Hoya M, Wiggins GAR, Lindy A, Vincent LM, Parsons MT, et al. Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup. Am J Hum Genet. 2023;110:1046\u201367.","journal-title":"Am J Hum Genet."},{"key":"1705_CR22","doi-asserted-by":"crossref","unstructured":"Tavtigian SV, Harrison SM, Boucher KM, Biesecker LG. Fitting a naturally scaled point system to the ACMG\/AMP variant classification guidelines. Hum Mut. 2020;41:1734\u20137.","DOI":"10.1002\/humu.24088"},{"key":"1705_CR23","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00079","volume":"7","author":"S Makhnoon","year":"2023","unstructured":"Makhnoon S, Davidson E, Shirts B, Arun B, Shete S. Practices and Views of US Oncologists and Genetic Counselors Regarding Patient Recontact After Variant Reclassification: Results of a Nationwide Survey. JCO Precis Oncol. 2023;7:e2300079.","journal-title":"JCO Precis Oncol."},{"key":"1705_CR24","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.ajhg.2022.10.006","volume":"109","author":"E Tudini","year":"2022","unstructured":"Tudini E, Andrews J, Lawrence DM, King-Smith SL, Baker N, Baxter L, et al. Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation. Am J Hum Genet. 2022;109:1960\u201373.","journal-title":"Am J Hum Genet."},{"key":"1705_CR25","doi-asserted-by":"crossref","unstructured":"Li L, Tian X, Woodzell V, Gibbs RA, Yuan B, Venner E. Tracking updates in clinical databases increases efficiency for variant reanalysis. Genet Med Open. 2024;2:101841.","DOI":"10.1016\/j.gimo.2024.101841"},{"key":"1705_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/humu.24152","volume":"42","author":"C Fortuno","year":"2021","unstructured":"Fortuno C, Lee K, Olivier M, Pesaran T, Mai PL, de, et al. Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53 variants. Hum Mutat. 2021;42:223\u201336.","journal-title":"Hum Mutat."},{"key":"1705_CR27","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/humu.23636","volume":"39","author":"JL Mester","year":"2018","unstructured":"Mester JL, Ghosh R, Pesaran T, Huether R, Karam R, Hruska KS, et al. Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert Panel. Hum Mutat. 2018;39:1581\u201392.","journal-title":"Hum Mutat."},{"key":"1705_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/jmg-2022-108807","volume":"60","author":"X Luo","year":"2023","unstructured":"Luo X, Maciaszek JL, Thompson BA, Leong HS, Dixon K, Sousa S, et al. Optimising clinical care through CDH1-specific germline variant curation: improvement of clinical assertions and updated curation guidelines. J Med Genet. 2023;60:568\u201375.","journal-title":"J Med Genet."},{"key":"1705_CR29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/gim.2017.231","volume":"20","author":"HW Tuffaha","year":"2018","unstructured":"Tuffaha HW, Mitchell A, Ward RL, Connelly L, Butler JRG, Norris S, et al. Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genet Med. 2018;20:985\u201394.","journal-title":"Genet Med."},{"key":"1705_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jval.2020.09.016","volume":"24","author":"A Koldehoff","year":"2021","unstructured":"Koldehoff A, Danner M, Civello D, Rhiem K, Stock S, M\u00fcller D. Cost-Effectiveness of Targeted Genetic Testing for Breast and Ovarian Cancer: A Systematic Review. Value Health. 2021;24:303\u201312.","journal-title":"Value Health."},{"key":"1705_CR31","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1001\/jamaoncol.2019.3323","volume":"5","author":"L Sun","year":"2019","unstructured":"Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, et al. A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer. JAMA Oncol. 2019;5:1718\u201330.","journal-title":"JAMA Oncol."},{"key":"1705_CR32","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/humu.24468","volume":"43","author":"AL Davidson","year":"2022","unstructured":"Davidson AL, Kondrashova O, Leonard C, Wood S, Tudini E, Hollway GE, et al. Analysis of hereditary cancer gene variant classifications from ClinVar indicates a need for regular reassessment of clinical assertions. Hum Mutat. 2022;43:2054\u201362.","journal-title":"Hum Mutat."},{"key":"1705_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/jmg-2023-109488","volume":"61","author":"N Walsh","year":"2024","unstructured":"Walsh N, Cooper A, Dockery A, O\u2019Byrne JJ. Variant reclassification and clinical implications. J Med Genet. 2024;61:207\u201311.","journal-title":"J Med Genet."},{"key":"1705_CR34","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.gim.2022.05.002","volume":"24","author":"L Loong","year":"2022","unstructured":"Loong L, Garrett A, Allen S, Choi S, Durkie M, Callaway A, et al. Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK). Genet Med. 2022;24:1867\u201377.","journal-title":"Genet Med."}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01705-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01705-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01705-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T09:03:37Z","timestamp":1732871017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01705-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1038\/s41431-024-01705-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4352556\/v1","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This project has been approved by the QIMR Berghofer Medical Research Institute Human Research Ethics Committee (HREC) under QIMR HREC Approval P1051.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}